Determined to Make a Difference
One of our core values is that we are “determined to make a difference”, and we work hard every day to do our part in making the world a better place. Through HealthCert and in collaboration with other organisations, we provide doctors with valuable education aiming to improve the availability and delivery of primary care in our local communities and globally.
The HealthCert Doctors for Development Scholarship was established to provide access to quality education in the areas of skin cancer medicine and dermatology for physicians who practise in the world's least developed countries and are committed to providing care to their patients despite difficult circumstances. The goal of the scholarship is to enable these doctors to achieve better patient outcomes in their home countries by applying and sharing the knowledge they acquired in the online certificate courses delivered by HealthCert.
The scholarship is available to physicians who work in general practice and who volunteer some of their time to care for patients in need. Eligible physicians must permanently reside and practise in a developing country. Non-native English speaking applicants must have sufficient proficiency in the English language to be able to follow the video lectures and participate in forum discussions. Participants must have basic computer skills and have access to the internet
We are proud to support UK’s most popular education program for GPs. In 2014, GP Update set up a social enterprise, Primary Care International (PCI), to extend its reach outside of the UK. Revenue from GP Update courses delivered by HealthCert will be used to support PCI’s operational costs as it develops projects in low and middle-income countries. These projects include health worker training on Non-Communicable Diseases in refugee camps and other humanitarian settings, as well as partnering with African organisations to test new approaches to primary care through a Healthcare Innovation Programme.
Currently funded projects include:
HealthCert supports the professional development of GP Registrars through a special scholarship. Doctors in training who are on a recognised pathway to General Practice Registration through a recognised training provider receive a HealthCert Scholarship of $500 for all face-to-face certificate courses and $350 for all online certificate courses.
GPs are expected to manage patients with skin cancer and other dermatological concerns in primary care, especially if they take a position in regional areas with very limited access to specialist care. However, these subjects are often undertaught at medical schools and GPs entering the workforce might feel underequipped to manage these patients. The HealthCert certificate courses aim to equip the doctors with the necessary skills to manage these conditions with confidence and improve patient outcomes in primary care. The courses also offer an essential step towards
With the majority of skin cancer work managed in primary care, every practising GP should have fundamental skin cancer diagnosis skills to help improve patient outcomes and save lives. The free online course is based on the suite of university quality-assured skin cancer certiﬁcate courses which have been attended by thousands of medical professionals worldwide. The objective of the short course is to provide GPs with the fundamental knowledge required to screen and identify suspicious skin lesions in a busy general practice.
We are proudly supporting the Rotary Clubs of Southport and Broadbeach who have initiated a fundraising project to aid further development of a Malaria vaccine created by Griffith University. There are around 3.2 billion people living in Malaria endemic areas worldwide and, in 2015, there were approximately 438,000 deaths – mostly children under five years. Vaccination is the key to eradicating the disease but, despite international efforts, no such vaccine exists.
Please help us support this promising project by donating to Rotary. The funds will help progress the vaccine into the next stage of clinical trials.